Liver Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2072-2079
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2072
Table 2 Expression of HSPs in hepatocarcinogenesis obtained by dot immunoblot analysis.
HSPTumor/ non-tumorDN
HCC
P (r)
LGDN (n = 11)HGDN (n = 8)E-HCC (n = 5)GI (n = 12)GII (n = 11)GIII (n = 10)
HSP27< 0.511
0.5-1.5963440.0021
1.5-2.5212622(0.407)
> 2.52354
HSP60< 0.51
0.5-1.510644540.0041
1.5-2.5121464(0.372)
> 2.532
HSP70< 0.5
0.5-1.56733250.100
1.5-2.552484(0.220)
> 2.51511
HSP90< 0.51
0.5-1.55632220.0071
1.5-2.5621476(0.353)
> 2.5622
GRP78 < 0.511
0.5-1.55332320.0071
1.5-2.554143(0.355)
> 2.511657
GRP94< 0.51
0.5-1.57121540.571
1.5-2.5263541(0.077)
> 2.521624